Rentschler Biopharma SE, a contract development and manufacturing organisation (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), today announced that Senta Brandt has been promoted to the global position of Head of Transformation, based at the company’s Laupheim site.
Gerrick Rodrigues has been promoted to Global Head of IT, based at the Milford site.
With their new appointments, Senta Brandt and Gerrick Rodrigues are joining the Global Leadership Team and will apply their expertise across the company.
Dr. Christian Schetter, CSO of Rentschler Biopharma, said: “I am delighted to announce the promotion of both colleagues, who have demonstrated strong leadership skills and capabilities in their areas.”
He continues: “What sets Senta apart is her long experience working in both our production and transformation teams, her in-depth knowledge of our processes and corporate culture.”
“Gerrick has been with Rentschler at our Milford site for more than three years and knows our systems and IT structure inside and out. He is part of the site leadership team and has successfully developed and managed the local team responsible for digital infrastructure and technologies.”
In her new role, Ms. Brandt will drive continuous improvement and innovation in the areas of operational efficiency and change processes. She has held various positions in production and transformation during her tenure at Rentschler Biopharma. Senta Brandt consistently demonstrated her strong skill set and team-building capabilities and is valued by the entire workforce.
In his new position as Global Head of IT, Gerrick Rodrigues will lead the IT organization to deliver technology solutions and services that can be leveraged for high performance across the Company. Leading a team of skilled professionals, he will continuously improve processes and capabilities.
